NCT02659709

Brief Summary

To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2015

Completed
6 months until next milestone

First Posted

Study publicly available on registry

January 20, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

August 5, 2019

Completed
Last Updated

August 5, 2019

Status Verified

June 1, 2019

Enrollment Period

1.3 years

First QC Date

August 6, 2015

Results QC Date

December 15, 2017

Last Update Submit

June 17, 2019

Conditions

Keywords

GlaucomaSmartphoneTabletApplicationEye Drops

Outcome Measures

Primary Outcomes (2)

  • Patients Owning Smartphone/Tablet Technology

    Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

    1 hour

  • Patients Having Access to Social Media Via Smartphone or Tablet in the Home

    Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

    1 hour

Secondary Outcomes (2)

  • Glaucoma Medication Compliance

    1 hour

  • Use of Medication Reminder

    1 hour

Study Arms (1)

Glaucoma Patients and Caregivers

Glaucoma patients and caregivers will complete a 20 item questionnaire providing demographic information, glaucoma eye drop compliance, interest in medication reminders, availability to smartphone, tablet and social media technology and interest in using a glaucoma application on social media.

Device: Interest in medical education through social media

Interventions

Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.

Also known as: Glaucoma App Interest
Glaucoma Patients and Caregivers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Glaucoma patients or care givers

You may qualify if:

  • Anyone affected by glaucoma
  • Family and friends of someone with glaucoma

You may not qualify if:

  • unable to complete survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wills Eye Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

Related Publications (1)

  • Waisbourd M, Dhami H, Zhou C, Hsieh M, Abichandani P, Pro MJ, Moster MR, Katz LJ, Hark LA, Myers JS. The Wills Eye Glaucoma App: Interest of Patients and Their Caregivers in a Smartphone-based and Tablet-based Glaucoma Application. J Glaucoma. 2016 Sep;25(9):e787-91. doi: 10.1097/IJG.0000000000000504.

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Limitations and Caveats

Participants were recruited from single urban eye care hospital. Results did not distinguish between glaucoma patients and caregivers. Participation did not include testing of the application.

Results Point of Contact

Title
Dr. Jonathan S. Myers
Organization
Wills Eye Hospital, Glaucoma Service

Study Officials

  • Jonathan S Myers, MD

    Wills Eye Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 6, 2015

First Posted

January 20, 2016

Study Start

June 1, 2015

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

August 5, 2019

Results First Posted

August 5, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations